Related to baseline ‘demographics and AE’
|
Demographics
|
Date of birth and date of enrolment into registry
|
Gender
|
Ethnicity
|
Educational status
|
Current occupation or education
|
AE diagnosis
|
How diagnosis AE is established
|
Use of validated diagnostic criteria
|
Date of onset AE
|
Past AE treatments
|
Previous phototherapy
|
Previous systemic therapy
|
Current AE treatments
|
Phototherapy
|
Systemic immunosuppressive therapy
|
Family history of AE or allergic diseases
|
Related to baseline ‘past medical relevant history’
|
Allergic comorbidities
|
Asthma
|
Allergic rhinoconjunctivitis
|
Atopic eye disease
|
Eosinophilic oesophagitis
|
Food allergies
|
Contact allergies
|
Other comorbidities
|
Past malignancies
|
Past serious infections
|
Related to baseline ‘investigations and assessments’
|
Baseline safety investigations
|
Medical history (tuberculosis)
|
Full blood count
|
Liver function
|
Kidney profile
|
Related to follow-up visits
|
Follow up ‘adverse drug reactions’
|
Serious adverse events
|
Adverse events that cause stop or switch of therapy or change in dosage
|
For (serious) adverse events: probability of relationship with treatment
|
Follow-up ‘management’
|
Reason for switching therapy
|
Reason for discontinuation of therapy
|